Author/Authors :
Alizadeh, Ali Akbar Biotechnology Research Center - Tabriz University of Medical Sciences, Tabriz, Iran , Hamzeh Mivehroud, Maryam Biotechnology Research Center - Tabriz University of Medical Sciences, Tabriz, Iran , Haddad, Elnaz School of Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran , Haddad, Nazanin School of Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran , Sharifi, Mehdi School of Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran , Mohammadi, Samin School of Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran , Pourtaghi, Samira School of Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran , Dastmalchi, Siavoush School of Pharmacy - Tabriz University of Medical Sciences, Tabriz, Iran
Abstract :
Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine which plays crucial roles
in pathogenesis of inflammatory diseases. The current study aimed to investigate the binding
abilities of I44 and I49 domain antibodies to TNF-α. The dAbs were expressed in bacterial
expression system and purified by affinity chromatography using Ni-sepharose column. The
expression and purity of the proteins were evaluated using western blotting and SDS-PAGE
techniques, respectively. ELISA experiment showed that I44 and I49 dAbs bind to TNF-α with
the binding constants (Kd) of 5.18 ± 1.41 and 2.42 ± 0.55 μM, respectively. The inhibitory
effect of dAbs on TNF-α biological effect was determined in MTT assay in which I44 and
I49 prevented TNF-α cell cytotoxicity with IC50 values of 6.61 and 3.64 μM, respectively. The
identified anti-TNF-α dAbs could bind to and inhibit TNF-α activity. The dAbs activities can
be attributed to their ability to establish hydrogen bonds as well as hydrophobic contacts with
TNF-α. The results of the current study can pave the way for further structural studies in order
to introduce new more potent anti-TNF-α antibodies.
Keywords :
Phage display , Molecular docking , Recombinant protein production , TNF-α , Domain antibodies